Switch to: References

Add citations

You must login to add citations.
  1. Ethics of early detection of disease risk factors: A scoping review.Sammie N. G. Jansen, Bart A. Kamphorst, Bob C. Mulder, Irene van Kamp, Sandra Boekhold, Peter van den Hazel & Marcel F. Verweij - 2024 - BMC Medical Ethics 25 (1):1-16.
    Background Scientific and technological advancements in mapping and understanding the interrelated pathways through which biological and environmental exposures affect disease development create new possibilities for detecting disease risk factors. Early detection of such risk factors may help prevent disease onset or moderate the disease course, thereby decreasing associated disease burden, morbidity, and mortality. However, the ethical implications of screening for disease risk factors are unclear and the current literature provides a fragmented and case-by-case picture. Methods To identify key ethical considerations (...)
    Download  
     
    Export citation  
     
    Bookmark  
  • Letter to the Editor.Jeannie Pasacreta, Nancy Press, Jennifer Fishman & Barbara Koenig - 2001 - Nursing Ethics 8 (2):161-163.
    Download  
     
    Export citation  
     
    Bookmark  
  • Database Research: Public and Private Interests.Vilhjálmur Árnason - 2011 - Cambridge Quarterly of Healthcare Ethics 20 (4):563-571.
    Download  
     
    Export citation  
     
    Bookmark   6 citations  
  • Letter to the Editor.N. Press, J. Fishman & B. Koenig - 2001 - Nursing Ethics 8 (2):161-163.
    Download  
     
    Export citation  
     
    Bookmark  
  • Should Researchers Offer Results to Family Members of Cancer Biobank Participants? A Mixed-Methods Study of Proband and Family Preferences.Deborah R. Gordon, Carmen Radecki Breitkopf, Marguerite Robinson, Wesley O. Petersen, Jason S. Egginton, Kari G. Chaffee, Gloria M. Petersen, Susan M. Wolf & Barbara A. Koenig - 2019 - AJOB Empirical Bioethics 10 (1):1-22.
    Background: Genomic analysis may reveal both primary and secondary findings with direct relevance to the health of probands’ biological relatives. Researchers question their obligations to return findings not only to participants but also to family members. Given the social value of privacy protection, should researchers offer a proband’s results to family members, including after the proband’s death? Methods: Preferences were elicited using interviews and a survey. Respondents included probands from two pancreatic cancer research resources, plus biological and nonbiological family members. (...)
    Download  
     
    Export citation  
     
    Bookmark   2 citations  
  • Risking ‘Safety’: Breast Cancer, Prognosis, and the Strategic Enterprise of Life.Nadine Ehlers - 2016 - Journal of Medical Humanities 37 (1):81-94.
    Living in modern biopolitical risk culture might be seen as synonymous with living in prognosis time, in the sense that risk of illness is endlessly forecast (prognosticated) in the broad social arena. ‘Safety,’ in this context, is framed as the anticipatory guarding against risk or disease in order to ‘make live.’ Thinking of risk and safety in these ways is limited, however, in that the prognosis cannot account for the individual’s life or death drama. This paper asks: how are we (...)
    Download  
     
    Export citation  
     
    Bookmark   1 citation